Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
25,378,604
-
Total 13F shares
-
3,939,093
-
Share change
-
+1,819,626
-
Total reported value
-
$6,026,447
-
Price per share
-
$1.53
-
Number of holders
-
20
-
Value change
-
+$2,578,454
-
Number of buys
-
13
-
Number of sells
-
7
Institutional Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q4 2025
As of 31 Dec 2025,
Medicus Pharma Ltd. - Common shares, no par value (MDCX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,939,093 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Interchange Capital Partners, LLC, Private Advisor Group, LLC, JANE STREET GROUP, LLC, Wilmington Savings Fund Society, FSB, SUSQUEHANNA INTERNATIONAL GROUP, LLP, May Hill Capital, LLC, BlackRock, Inc., COMMONWEALTH EQUITY SERVICES, LLC, and HRT FINANCIAL LP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.